Publications by authors named "Debra Marshall"

Claim this Profile
N
Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial.
Connie N Hess, Judith Hsia, Ian A Carroll, Mark R Nehler, Wolfram Ruf, Debra Marshall

Arterioscler Thromb Vasc Biol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caregiver Faculty: Working through a Pandemic.
Debra Marshall, Sara Hoskin

J Appl Soc Sci (Boulder)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial.
Connie N Hess, Warren H Capell, Michael R Bristow, Wolfram Ruf, Michael Szarek, Debra Marshall

Am Heart J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Clinical Validation of a Novel Quality Management System for Blood Gas, Electrolytes, Metabolites, and CO-Oximetry.
James H Nichols, Tony Cambridge, Neldis Sanchez, Debra Marshall

J Appl Lab Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-limiting, adverse event-associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial.
William T Abraham, Jonathan P Piccini, Christopher Dufton, Ian A Carroll, Jeffrey S Healey, Debra Marshall

Heart Rhythm O2· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Validation of a Novel Quality Management System for Blood Gas, Electrolytes, Metabolites, and CO-Oximetry.
James H Nichols, Tony Cambridge, Neldis Sanchez, Debra Marshall

J Appl Lab Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the Arg389Arg Genotype.
Jonathan P Piccini, Christopher Dufton, Ian A Carroll, Jeff S Healey, William T Abraham, Debra Marshall

Circ Arrhythm Electrophysiol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.
Jonathan P Piccini, William T Abraham, Christopher Dufton, Ian A Carroll, Jeff S Healey, Debra Marshall

JACC Heart Fail· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial.
Jonathan P Piccini, Stuart J Connolly, William T Abraham, Jeff S Healey, Benjamin A Steinberg, Debra A Marshall

Am Heart J· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of a one-year lifestyle intervention program on carotid intima media thickness.
Debra Marshall, Walizer Elaine, Marina Vernalis

Mil Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
Chee Tang Chin, Matthew T Roe, Keith A A Fox, Dorairaj Prabhakaran, Debra A Marshall

Am Heart J· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study.
Gilles Montalescot, Georgios Sideris, Remy Cohen, Catherine Meuleman, Claire Bal dit Sollier, Debra Marshall

Thromb Haemost· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achievement of heart health characteristics through participation in an intensive lifestyle change program (Coronary Artery Disease Reversal Study).
Debra A Marshall, Elaine M Walizer, Marina N Vernalis

J Cardiopulm Rehabil Prev· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations.
Janet E Stout, Robert R Muder, Sue Mietzner, Marilyn M Wagener, Mary Beth Perri, Debra Marshall

Infect Control Hosp Epidemiol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of exercise in modulating the impact of an ultralow-fat diet on serum lipids and apolipoproteins in patients with or at risk for coronary artery disease.
Debra A Marshall, Marina N Vernalis, Alan T Remaley, Elaine M Walizer, John P Scally

Am Heart J· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal healing environments for chronic cardiovascular disease.
Debra A Marshall, Elaine Walizer, Marina N Vernalis

J Altern Complement Med· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive lifestyle modification: impact on cardiovascular disease risk factors in subjects with and without clinical cardiovascular disease.
Darrell L Ellsworth, Sean C O'Dowd, Barbara Salami, Alan Hochberg, Marina N Vernalis, Debra Marshall

Prev Cardiol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis